v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2025
Mar. 31, 2024
Assets    
Cash and cash equivalents $ 4,052 $ 1,670
Finance receivables, net of allowance for credit losses of $396 and $353 52,516 47,248
Investment in operating leases, net 30,596 27,378
Income taxes receivable 0 79
Other assets 1,270 1,214
Derivative instruments 389 743
Total assets 88,969 78,469
Liabilities and Equity    
Debt 62,547 50,917
Income taxes payable 505 148
Deferred income taxes 5,302 5,701
Derivative instruments 1,120 1,472
Total liabilities 71,290 59,846
Commitments and contingencies (Note 9)
Shareholder’s equity:    
Common stock, $100 par value. Authorized 15,000,000 shares; issued and outstanding      13,660,000 shares as of March 31, 2025 and 2024 1,366 1,366
Retained earnings 15,448 16,254
Accumulated other comprehensive loss (209) (137)
Total shareholder’s equity 16,605 17,483
Noncontrolling interest in subsidiary 1,074 1,140
Total equity 17,679 18,623
Total liabilities and equity 88,969 78,469
Variable Interest Entity, Primary Beneficiary    
Assets    
Finance receivables, net of allowance for credit losses of $396 and $353 12,969 9,796
Other assets 755 740
Total assets 13,724 10,536
Liabilities and Equity    
Debt 12,384 9,351
Due to Parent and affiliated companies and Other liabilities 22 17
Total liabilities 12,406 9,368
Affiliated Entity    
Assets    
Due from Parent and affiliated companies 146 137
Liabilities and Equity    
Due to Parent and affiliated companies and Other liabilities 181 153
Nonrelated Party and Affiliated Entity    
Liabilities and Equity    
Due to Parent and affiliated companies and Other liabilities $ 1,635 $ 1,455